“…By determining the size of the tumor, US enables for customized surgical planning for BCC, and it can assist in monitoring early BCC recurrence [ 49 , 50 , 51 ]. Moreover, other morphological data such as tumor width, length and aspect can be identified on HFUS examinations and patients’ therapy can be impacted by this (e.g., if HFUS identifies a superficial BCC, therapies such as photodynamic therapy and cryotherapy can also be used) [ 45 , 47 , 48 , 52 ]. In a study by Desai et al, because of HFUS they had better therapy results with a clearance rate of 90% [ 52 ].…”